Compare Aurora Cannabis Inc (ACB) vs Moderna, Inc. (MRNA) Price & Performance

Aurora Cannabis IncTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Aurora Cannabis Inc vs Moderna, Inc. — how do they compare? Aurora Cannabis Inc trades at $3.45 (market cap $223.59M), while Moderna, Inc. trades at $60.75 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 108.1× Aurora Cannabis Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.

	ACB	MRNA
Market Cap	$223.59M	$24.18B
Sector	Health	Health
52-Week High	$6.23	$81.80
52-Week Low	$2.58	$22.36
Enterprise Value	$168.09M	$20.33B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ACB

Aurora Cannabis reviews unsolicited $4/share takeover bid from Curaleaf, no decision yet.PRNewsWire · 19 hours agoNeutral Curaleaf launches hostile bid to acquire Aurora Cannabis at $4 per share, offering shares plus cash.Proactive Investors · 20 hours agoBullish Curaleaf offers to buy Aurora Cannabis with a 45% premium, aiming to create a leading global cannabis platform.PRNewsWire · 1 day agoBullish View details →

MRNA

View details →

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.